1-9 of 9
Jaeyoon John Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Leptin-Enhanced JAK-STAT Signaling in Acute Myeloid Leukemia-Derived Mesenchymal Stromal Cells and Its Implications for Disease Progression

Muzaffar Bhatti, Anthea Travas, Oyeronke Ayansola, Amirthagowri Ambalavanan, Jaeyoon John Kim, Danielle Pyne, Troy Ketela, Andrea Arruda, Mark D. Minden, Armand Keating, Dennis Dong Hwan Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 5664.
https://doi.org/10.1182/blood-2024-211349
Published: 2024
Journal Articles

Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML Patients

May Chiu, Maria Agustina Perusini, Jaeyoon John Kim, Danielle Pyne, Muzaffar Bhatti, Anthea Travas, Oyeronke Ayansola, Amirtha Ambalavanan, Jenny Ho, Dennis Dong Hwan Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 1768.
https://doi.org/10.1182/blood-2024-204999
Published: 2024
Journal Articles

Retrospective Evaluation of BCR::ABL Kinase Domain Mutation Profiles and Treatment Outcomes in Patients with Chronic Myeloid Leukemia to Confirm Clinical Relevance of in Vitro Sensitivity-Based Treatment Switch: Real-World Experience

Maria Agustina Perusini, Eleanore Louise Musick, Filza Gul, May Chiu, Mohammad Alwadi, Noora Obaidallah, Jaeyoon John Kim, Danielle Pyne, Jose-Mario Capo-Chichi, Dennis Dong Hwan Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 3810.
https://doi.org/10.1182/blood-2024-210449
Published: 2024
Journal Articles

New Pattern of Emerging Somatic Mutations in Optimal Responders Following Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients Evidenced from Mutational Kinetic Analysis Based on Pairwise Comparison

Gopila Gupta, May Chiu, Eshrak Al-Shaibani, Maria Agustina Perusini, Josephine Lucero, Daniela Zackova, Ivana Jeziskova, Anezka Kvetkova, Tomas Jurcek, Jaeyoon John Kim, Danielle Pyne, Anthea Travas, Amirthagowri Ambalavanan, Jiri Mayer, Jessie Medeiros, Sagi Abelson, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4531.
https://doi.org/10.1182/blood-2023-189827
Published: 2023
Journal Articles

Presence of Recurrent Somatic Mutations in Mesenchymal Stromal Cell Fractions Isolated from Acute Myeloid Leukemia As an Evidence of Clonality

Muzaffar Bhatti, Taehyung Kim, Jenny Warrington, Amirthagowri Ambalavanan, Sarah Zarabi, Anthea Travas, Jaeyoon John Kim, Danielle Pyne, Troy Ketela, Andrea Arruda, Mark D. Minden, Armand Keating, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6042.
https://doi.org/10.1182/blood-2023-185149
Published: 2023
Journal Articles

Final Report: Somatic Mutations and HMGCLL1 Haplotype Are Not Associated with Molecular Relapse-Free Survival in Patients with Chronic Myeloid Leukemia Who Attempt Treatment-Free Remission

Maria Agustina Perusini, Katia Pagnano, Carolina Pavlovsky, Beatriz Moiraghi, Ana Varela, Michele Bianchini, Carmen Fava, Jiří Mayer, Daniela Žáčková, Anežka Kvetková, Tomáš Jurček, Ivana Ježíšková, Ana Beatriz Pascoal Lopes, Gislaine Borba Oliveira, Carmino De Souza, Amirthagowri Ambalavanan, Anthea Travas, Jaeyoon John Kim, Danielle Pyne, Jessie Medeiros, Sagi Abelson, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4543.
https://doi.org/10.1182/blood-2023-189797
Published: 2023
Journal Articles

The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis

Ayman Sayyed, Hyewon Lee, Taehyung Simon Kim, Jaeyoon John Kim, Danielle Pyne, Nathali Kaushansky, Yardena Brilon, Noa Chapal-Ilani, Tamir Biezuner, Liran I. Shlush, Jan Storek, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 2207.
https://doi.org/10.1182/blood-2023-191191
Published: 2023
Journal Articles

In Vitro Evidence of Synergistically Enhanced Efficacy of Axitinib When Combined with Asciminib in T315I Mutated Chronic Myeloid Leukemia

Ho-Jae Han, Eun-Ju Park, Jaeyoon John Kim, Danielle Pyne, Anthea Travas, Amirthagowri Ambalavanan, Shinya Kimura, Michael W. Deininger, Jong-Won Kim, Dennis D. H. Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6336.
https://doi.org/10.1182/blood-2023-185440
Published: 2023
Journal Articles

Asciminib Enhances Its Treatment Efficacy Synergistically in the Treatment of Chronic Myeloid Leukemia Harboring ABL1 Kinase Domain Mutation When Combined with a Reduced Dose of Ponatinib, Dasatinib, or Bosutinib, but Not with Nilotinib or Imatinib

Ho-Jae Han, Jaeyoon John Kim, Danielle Pyne, Anthea Travas, Amirthagowri Ambalavanan, Shinya Kimura, Michael W. Deininger, Jong-Won Kim, Dennis D. H. Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6337.
https://doi.org/10.1182/blood-2023-188135
Published: 2023